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111Treatment of a patient with vertebral and subclavian
aneurysms in the setting of a TGFBR2 mutation
Joshua Sylvan,a Roy K. Greenberg, MD,a Tara M. Mastracci, MD,a Matthew J. Eagleton, MD,a and
Rocio Moran, MD,b Cleveland, Ohio
We present the case of a patient diagnosed with hypermobile Ehlers-Danlos syndrome with aneurysms of the subclavian
and vertebral arteries. Molecular testing demonstrated transforming growth factor-beta receptor type 2 mutation. She
was not a candidate for an open repair; therefore, a hybrid approach involving right vertebral ligation and bypass from the
right common carotid to the vertebral C1-2 interface, endovascular exclusion of the left vertebral artery, and stent
grafting of the left subclavian/axillary artery was used. The left vertebral embolization proved ineffective, requiring
a right-to-left vertebral catheterization with glue occlusion. Based on her proper molecular diagnosis, she underwent
prophylactic root and ascending aortic repair. (J Vasc Surg 2013;57:1116-9.)Connective tissue disorders affecting the vasculature can
often create scenarios that challenge clinicians with respect
to diagnosis and management strategies. Ehlers-Danlos
syndrome (EDS) is a disorder characterized by skin and joint
hypermobility and easy bruising, among many other notice-
able features.1-3 Phenotypic similarities between types are
common, but important differences exist in the effect of
the genetic mutation on the vasculature. Gene sequencing
is now the primary molecular diagnostic method used, and
speciﬁc treatment recommendations rely on accurate molec-
ular analyses. Such data have resulted in the reclassiﬁcation
of patients previously diagnosed based on clinical criteria
alone.4,5 The use of endovascular therapies in such patients
remains poorly understood and mandates the development
of paradigms to treat such conditions.6,7 We present the
interesting case of a patient with a historical diagnosis of
EDS with multiple aneurysms requiring treatment.
CASE REPORT
A 26-year-old woman presented with a complex medical history
including inguinal and umbilical hernia repair at age 1 year; repair of
severe pectus deformity at age 4 years; clinical diagnosis of type III
EDS at age 18 years; mitral valve replacement at age 18 years compli-
cated by left ventricular dysfunction, congestive heart failure, and
pulmonary issues; and uneventful pregnancy at age 25 years.
At the age of 27 years, she presented with supraventricular
tachycardia.During the course of herworkup, a left subclavian aneu-
rysm was noted, prompting her referral. On clinical examination,
she had a palpable, tender supraclavicular pulsatile mass and a biﬁd
uvula. Detailed imaging demonstrated a slightly dilated ascendingthe Department of Vascular and Endovascular Surgery,a and the
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6aorta (3.2 cm), a large left subclavian aneurysm (4.5 cm), and bilat-
eral multiple vertebral aneurysms extending from the origin of the
vessels through the mid-neck with an intact posterior circle of Willis
(Fig 1). Cardiac workup revealed signiﬁcant (recurrent) mitral
valvular insufﬁciency with an ejection fraction of 25%. Her clinical
features prompted reassessment of her connective tissue disorder
diagnosis. Molecular testing conﬁrming a transforming growth
factor-beta receptor type 2 (TGFBR2) mutation, with normal
construct of COL3A1. She was believed to be a poor candidate
for an open chest surgical procedure.
There was a short straight proximal (7-mm diameter) left
subclavian artery neck. Both of her vertebral arteries had a signiﬁcant
amount of aneurysmal disease. The aneurysms were treated with
a hybrid repair in a staged fashion (Fig 2): (1) ligation of the right
vertebral artery at the origin and at C2 with a reversed saphenous
vein graft from the right common carotid artery to the distal aspect
of the vertebral at C2; and (2) left subclavian/axillary stent graft
placement with coil embolization of the left vertebral artery.
Complex helical coils (Boston Scientiﬁc, Natick, Mass) were deliv-
ered into the proximal left vertebral artery, internal mammary,
thyrocervical, and costocervical trunks through a Renegade micro-
catheter (Boston Scientiﬁc). Two self-expanding stent grafts were
used to bridge the aneurysm into the axillary artery (proximally:
Fluency; C. R. Bard, Murray Hill, NJ; distally: Viabahn; W. L.
Gore & Associates, Flagstaff, Ariz). The proximal sealing zone was
reinforced with a balloon-expandable Atrium stent graft (Atrium
Medical, Hudson, NH) to ensure circumferential wall apposition.
The entire stent graft section was relined with a single self-
expanding stent in an effort to minimize the risk of kinking and to
better ensure appropriate overlap over time.
The patient recovered from the procedure without any adverse
events. However, at her 1-month follow-up visit, she complained
of persistent pain in the left supraclavicular fossa, and the mass
remained pulsatile.Duplex ultrasound study revealed a sizable endo-
leak that was thought to be type III in nature. Angiographywas then
performed, but we were unable to demonstrate any endoleak with
selective left subclavian artery injections. When the right vertebral
bypass was catheterized and injected, retrograde perfusion of the
aneurysm was noted via the left vertebral artery through the embo-
lization coils (Fig 3). Given the failure of coil embolization, we elec-
ted to ﬁll the artery with cyanoacrylate glue (Cordis, Great Lakes,
Fig 1. A, Best demonstration of the extent of the patient’s aneu-
rysmal disease. Note the aneurysms throughout the cervical portion
of the right vertebral, large aneurysm of the left subclavian, and
origin of the left vertebral arteries. B, Reconstructed computed
tomographic image.
Fig 2. A, Total repair with a saphenous vein graft originating from
the proximal right carotid artery and terminating end to end with the
right vertebral at the C1-2 interface, a stent graft traversing the left
subclavian aneurysm, and coil embolization of the left proximal
vertebral artery. B, Computed tomographic reconstruction demon-
strating the proximal balloon-expandable stent extending slightly into
the aorta. C, Angiographic image showing the self-expanding stent
grafts into the axillary artery.
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sheath was guided into the right common carotid artery. Selective
access was gained through the sheath with aGlidewire glide catheter
(Boston Scientiﬁc) and a Prowler Plus catheter (Cordis) into the
vertebral bypass, and then through the circle of Willis (similar to
an up-and-over technique) and into the proximal left vertebral
artery, where 2 mL of cyanoacrylate glue (Cordis), diluted 2:1
with Ethiodol, was slowly injected. This ﬁlled the aneurysm sac
and the proximal and mid-vertebral artery and eliminated the endo-
leak (Video, online only). The patient tolerated the procedure well.
Fig 3. Selective injection of contrast into the right vertebral artery
bypass, which traverses the circle of Willis (A) and then travels
retrograde into the left subclavian aneurysm through the coils (B).
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The patient has continued to do well after her repair but has
required several additional procedures to address vascular complica-
tions relating to the TGFBR2 mutation, including a root and
ascending aortic replacement when her proximal aortic diameter
exceeded 4.1 cm. At her 5-year follow-up visit, her subclavian aneu-
rysm remains excluded and is completely resorbed, as are her verte-
bral aneurysms. Her proximal descending thoracic aorta has dilated
to 3.4 cm, which remains a concern. Her vertebral bypass remains
patent, and there is no detectable residual vertebral pathology.
DISCUSSION
This patient presented with a diagnosis of hyper-
mobile EDS but with extensive vascular manifestations that
prompted re-examination of her diagnosis. Comorbiditiesprecluded an open chest repair, and she was treated with
a hybrid procedure.Her initially incomplete aneurysm exclu-
sion was salvaged with microcatheter embolization tech-
niques At the time of the patient’s presentation, TGFBR1
and TGFBR2 mutations were relatively new and showed
signiﬁcant clinical variability. The disease can be very aggres-
sive, with some reports stating an average life expectancy of
only 26.1 years.4 Accelerated monitoring and early treat-
ment of proximal aortic disease when the aortic root exceeds
4.1 cm in diameter have been advocated in an effort to miti-
gate the risks of dissection and rupture. These recommenda-
tions are speciﬁc to patients with TGFBR1 and TGFBR2
mutations.
The use of endovascular devices in such patients has
been viewed skeptically. Primary concerns relate to the
interface between the stent and the arterial wall. The use
of self-expanding stents at such interface sites is advocated
in an effort to provide a gradient stiffness as the stent graft
transitions to the vessel wall (balloon-expandable stents are
likely too stiff), limiting the risk of vessel wall erosion.
Thrombosis is a separate issue, and should the entire repair
thrombose with the aneurysm treated, a carotid-to-axillary
bypass could be performed. We arguably believed that
preservation of anterograde ﬂow through at least one of
the two vertebral arteries would be advantageous in the
long term. The secondary procedure whereby catheters
were used to traverse the circle of Willis to embolize the
contralateral vertebral and subclavian endoleak may also
have been considered somewhat risky with dissection or
arterial rupture; however, her vessels tolerated well during
the initial procedure.
Ultimately, the management of such patients remains
complex. Molecular testing should be considered for atyp-
ical patient presentations because the treatment paradigms
may change. Little data pertaining to the durability of
open or endovascular repairs in patients with TGFBR1 and
TGFBR2 mutations is available; thus, one may argue that
there is no “gold standard” of treatment. The use of endo-
vascular techniques offers distinct advantages with respect
to invasiveness and access into surgically challenging beds,
yet discretion with respect to the durability and potential
for complications is advised.REFERENCES
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